Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
1-15 of 4721 results
Taiho Pharmaceutical exercises option to develop AB928 in its territories
Arcus Biosciences announced that Taiho Pharmaceutical has exercised its option to obtain an exclusive development and commercialization license to the company’s adenosine receptor antagonist program, which includes AB928 and back-up compounds, in Japan and certain other territories in Asia (excluding China).
Drug Research > Drug Discovery & Development > News
Genmab, Immatics to develop next-generation bispecific cancer immunotherapies
By PBR Staff Writer
Genmab has signed a collaboration and exclusive license agreement with Immatics Biotechnologies to work on next-generation bispecific cancer immunotherapies.
Drug Research > Drug Discovery & Development > News
Otsuka Pharmaceutical to buy biotechnology firm Visterra for $430m
By PBR Staff Writer
Otsuka Pharmaceutical has agreed to acquire clinical-stage biotechnology firm Visterra for around $430m.
Drug Research > Drug Discovery & Development > News
BioNTech, Genevant to co-develop mRNA drugs for rare diseases
Germany-based BioNTech has entered into a collaboration with Genevant Sciences to develop five of the former’s mRNA therapeutic programs for the treatment of rare diseases with high unmet medical need.
Drug Research > Drug Discovery & Development > News
BioCryst terminates merger deal with Idera Pharmaceuticals
By PBR Staff Writer
BioCryst Pharmaceuticals has failed to get approval from the stockholders for its merger deal with Idera Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
Teneobio, Janssen to develop multispecific antibodies for oncology
Teneobio has started a research collaboration and licensing agreement with Janssen Biotech to develop multi-specific antibodies for undisclosed oncology targets.
Drug Research > Drug Discovery & Development > News
Axovant, Benitec sign licensing deal for AXO-AAV-OPMD program
By PBR Staff Writer
Axovant Sciences has entered into a global licensing agreement with Benitec Biopharma for BB-301 (AXO-AAV-OPMD) platform to treat oculopharyngeal muscular dystrophy (OPMD).
Drug Research > Drug Discovery & Development > News
Cellect, denovoMATRIX to combine stem cell production technologies
Cellect Biotechnology, a developer of a stem cell production technology, has signed a collaboration and material transfer agreement with the denovoMATRIX group of the Technische Universität Dresden (TU Dresden).
Drug Research > Drug Discovery & Development > News
Aveo, Novartis scrap $326m antibody licensing deal
By PBR Staff Writer
US-based Aveo Pharmaceuticals and Swiss drugmaker Novartis have scrapped their $326m worth licensing agreement to develop and commercialize the former’s humanized inhibitory antibody AV-380 and other related antibodies.
Drug Research > Drug Discovery & Development > News
Catalent to buy Juniper Pharmaceuticals in $133m deal
By PBR Staff Writer
US-based Catalent has agreed to acquire Juniper Pharmaceuticals in a deal valued at around $133m.
Drug Research > Drug Discovery & Development > News
TRIGR Therapeutics, ABL Bio collaborate on next generation therapeutic antibodies
TRIGR Therapeutics and ABL Bio have entered into a binding agreement for TRIGR to license the global commercial rights to ABL Bio’s pipeline of novel therapeutic antibodies to treat cancer.
Drug Research > Drug Discovery & Development > News
Broad, Bayer expand partnership to develop therapies for heart failure
The Broad Institute of MIT and Harvard and Bayer are launching the Precision Cardiology Laboratory (PCL), a new endeavor that will pursue scientific insights aimed at developing new therapies for heart failure.
Drug Research > Drug Discovery & Development > News
Biogen to pay $700m to increase stake in Samsung Bioepis
Biogen has agreed to increase its stake in biopharmaceutical company Samsung Bioepis to nearly 49.9% in a deal of about $700m with its joint venture (JV) partner Samsung BioLogics.
Drug Research > Drug Discovery & Development > News
Lumicks, AstraZeneca and University of Cambridge create new drug discovery and biology center
LUMICKS has partnered with AstraZeneca and the University of Cambridge Biochemistry Department to form the Center of Excellence for Dynamic Single-Molecule Analysis for accelerated drug discovery and biology.
Drug Research > Drug Discovery & Development > News
AbbVie, Calibr partner to develop T-cell therapies for solid tumors
Biopharmaceutical firm AbbVie and Calibr, the drug discovery division of Scripps Research, have entered into a collaboration to develop T-cell therapies aimed mainly at cancer, including solid tumors.
Drug Research > Drug Discovery & Development > News
1-15 of 4721 results